ZyVersa Therapeutics, Inc. (ZVSA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 26.08K | 0 | 0 | 0 | 15.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | -100% | - | - | - | 67.17% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 13.04K | 1.73K | 2.6K | 10.44K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 0 | 2.6K | 2.6K |
| COGS % of Revenue | - | - | - | - | - | 50% | - | - | - | 16.67% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 13.04K | -1.73K | -2.6K | -10.44K | 13K | -2.6K | -2.6K | -2.6K | -2.6K | -2.6K | -2.6K | -2.6K | 0 | -2.6K | -2.6K |
| Gross Margin % | - | - | - | - | - | 50% | - | - | - | 83.33% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -100% | 100% | 100% | 100% | 0.3% | 33.35% | 0% | -301.5% | 600% | 0% | 0% | 0% | - | 0% | 0% | 0% | - | - | - |
| Operating Expenses | 1.3M | 551.86K | 2.1M | 2.04M | 2.14M | 1.29M | 2.27M | 2.75M | 2.82M | 1.77M | 2.9M | 5.15M | 4.59M | 4.37M | 3.4M | 1.88M | 3.37M | 1.78M | 2.11M | 1.85M |
| OpEx % of Revenue | - | - | - | - | - | 4933.66% | - | - | - | 11369.33% | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.25B | 472.62M | 1.74B | 1.63B | 1.89B | 1.17M | 1.83M | 2.04M | 2.3M | 1.52M | 2.23M | 3.93M | 3.54M | 3.08M | 1.06M | 1.16M | 2.3M | 1.14M | 1.71M | 1.35M |
| SG&A % of Revenue | - | - | - | - | - | 4468.72% | - | - | - | 9721.18% | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 57.62M | 79.24M | 365.05M | 409.94M | 258.88M | 121.25K | 436.04K | 709.05K | 512.94K | 257.11K | 673.94K | 1.22M | 1.06M | 1.29M | 2.33M | 719.39K | 1.07M | 633.97K | 406.95K | 496.51K |
| R&D % of Revenue | - | - | - | - | - | 464.93% | - | - | - | 1648.14% | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | -1000K | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.3M | 4.18B | -2.1M | -2.04B | -2.14B | -1.29M | -2.27M | -2.75M | -2.83M | -1.78M | -2.9M | -86.33M | -4.59M | -4.37M | -3.4M | -1.88M | -3.37M | -1.78M | -2.11M | -1.85M |
| Operating Margin % | - | - | - | - | - | -4933.66% | - | - | - | -11385.99% | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 99.94% | 325295.53% | 7.29% | -74124.7% | -75769.97% | 27.57% | 21.81% | 96.81% | 38.45% | 59.32% | 14.51% | -4483.45% | -36.33% | -145.76% | -60.57% | -1.77% | -71.61% | - | - | - |
| EBITDA | -1.3M | -426.75K | -20.53M | -2.08M | -2.26M | -1.29M | -2.27M | -2.75M | -2.82M | -1.77M | -2.9M | -86.32M | -4.59M | -4.36M | -3.39M | -1.88M | -3.37M | -1.77M | -2.11M | -1.85M |
| EBITDA Margin % | - | - | - | - | - | -4963.72% | - | - | - | -11369.33% | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 42.19% | 67.03% | -805.07% | 24.36% | 19.86% | 27.02% | 21.8% | 96.81% | 38.64% | 59.35% | 14.52% | -4489.64% | -36.36% | -145.97% | -60.65% | -1.78% | -71.71% | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | -7.84K | 1.73K | 2.6K | 10.44K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K | 2.6K |
| EBIT | -1.3M | -426.75K | -20.53M | -2.08M | -2.26M | -1.29M | -2.27M | -2.75M | -2.83M | -95.11M | -2.9M | -5.15M | -4.59M | -5.37M | -3.62M | -1.88M | -3.58M | -1.76M | -1.65M | -1.87M |
| Net Interest Income | -132.51K | -132.26K | -131.35K | -130.04K | -119.56K | -138.06K | -131.63K | 0 | -101 | 0 | -210 | -314 | 1.08K | -49.72K | -69.35K | -140.4K | -168.06K | -204.72K | -225.49K | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.08K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 132.51K | 132.26K | 131.35K | 130.04K | 119.56K | 138.06K | 131.63K | 0 | 101 | 0 | 210 | 314 | 0 | 49.72K | 69.35K | 140.4K | 168.06K | 204.72K | 225.49K | 0 |
| Other Income/Expense | -488.68K | 279.14M | -18.55M | -167.19M | -112.36M | -138.06K | -131.63K | 0 | -101 | -12.16M | -210 | -81.18M | 1.08K | -2.39M | -297.45K | -120.8K | -380.16K | -192.52K | 234.5K | -244.44K |
| Pretax Income | -1.79M | 4.46B | -20.66M | -2.21B | -2.26B | -1.42M | -2.4M | -2.75M | -2.83M | -13.93M | -2.9M | -86.33M | -4.59M | -4.6M | -3.69M | -2M | -3.75M | -1.97M | -1.88M | -2.1M |
| Pretax Margin % | - | - | - | - | - | -5463.08% | - | - | - | -89324.15% | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | -851.66K | 0 | 0 | -2.96K | 0 | 9.71K | 0 | -596.07K | -485 | -7.81M | -1.05M | 186.4K | 0 | -210.23K | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 4.12% | 0% | 0% | 0.21% | 0% | -0.35% | 0% | 4.28% | 0.02% | 9.05% | 22.81% | -4.05% | 0% | 10.49% | 0% | 0% | 0% | 0% |
| Net Income | -1.79B | -678.57K | -19.81M | -2.21M | -2.26M | -1.42M | -2.4M | -2.76M | -2.83M | -13.34M | -2.9M | -78.51M | -3.54M | -4.79M | -3.74M | -1.79M | -3.66M | -1.97M | -1.88M | -2.1M |
| Net Margin % | - | - | - | - | - | -5451.72% | - | - | - | -85503.21% | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -79361.08% | 52.27% | -724.8% | 19.99% | 20.16% | 89.34% | 17.27% | 96.48% | 20.24% | -178.54% | 22.4% | -4276.46% | 3.25% | -143.19% | -98.96% | 14.37% | -71.16% | - | - | - |
| Net Income (Continuing) | -1.79M | -678.57K | -19.81M | -2.21M | -2.26M | -1.42M | -2.4M | -2.76M | -2.83M | -13.34M | -2.9M | -78.51M | -3.54M | -4.68M | -3.69M | -2M | -3.75M | -1.97M | -1.88M | -2.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.22 | -0.08 | -2.56 | -0.46 | -0.73 | -1.31 | -2.43 | -3.31 | -4.53 | -32.92 | -33.16 | -1694.14 | -135.88 | -180.25 | -287.36 | -50.17 | -80.52 | -8.33 | -40.38 | -45.00 |
| EPS Growth % | 69.86% | 93.6% | -5.35% | 86.1% | 83.89% | 96.02% | 92.67% | 99.8% | 96.67% | 81.74% | 88.46% | -3277.09% | -68.75% | -2064.82% | -611.58% | -11.47% | -75.15% | - | - | - |
| EPS (Basic) | -0.22 | -0.08 | -2.56 | -0.46 | -0.73 | -1.31 | -2.43 | -3.31 | -4.53 | -32.92 | -33.16 | -1694.14 | -135.88 | -180.25 | -287.36 | -50.17 | -80.52 | -8.33 | -40.38 | -45.00 |
| Diluted Shares Outstanding | 8.1B | 5.96B | 77.41M | 48.14M | 3.11M | 1.09M | 988.38K | 834.91K | 623.6K | 405.2K | 88.51K | 51.02K | 26.08K | 25.95K | 46.55K | 46.55K | 46.55K | 28.65K | 46.55K | 46.55K |
| Basic Shares Outstanding | 8.1B | 5.96B | 77.41M | 48.14M | 3.11M | 1.09M | 988.38K | 834.91K | 623.6K | 405.2K | 88.51K | 51.02K | 26.08K | 25.95K | 46.55K | 46.55K | 46.55K | 28.65K | 46.55K | 46.55K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |